解决临床试验延误:创新解决方案

Kavita Singh, M. A. Salam, R. Devarajan, D. Prabhakaran
{"title":"解决临床试验延误:创新解决方案","authors":"Kavita Singh, M. A. Salam, R. Devarajan, D. Prabhakaran","doi":"10.4155/CLI.15.41","DOIUrl":null,"url":null,"abstract":"Our objective was to provide broad perspective on causes and consequences of clinical trial delays and suggest process-oriented and technology-enabled pragmatic solutions to minimize trial delays, in particular context of doing trials in India. The main challenges for successful completion of clinical trials stem from regulatory and ethics review, investigator selection, site initiations, participant recruitment and retention, monitoring and data management issues. Careful planning, sorting out ownership issues in the initial steps and a partnership based on shared issues among all the stakeholders will help reduce the trial delays. Such a shared vision will enable adherence to regulatory requirements, enhance the quality of trial conduct and ultimately enable improved access to new treatments and its benefits to the Indian population.","PeriodicalId":10369,"journal":{"name":"Clinical investigation","volume":"53 1","pages":"745-753"},"PeriodicalIF":0.0000,"publicationDate":"2015-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Solving clinical trial delays: innovative solutions\",\"authors\":\"Kavita Singh, M. A. Salam, R. Devarajan, D. Prabhakaran\",\"doi\":\"10.4155/CLI.15.41\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Our objective was to provide broad perspective on causes and consequences of clinical trial delays and suggest process-oriented and technology-enabled pragmatic solutions to minimize trial delays, in particular context of doing trials in India. The main challenges for successful completion of clinical trials stem from regulatory and ethics review, investigator selection, site initiations, participant recruitment and retention, monitoring and data management issues. Careful planning, sorting out ownership issues in the initial steps and a partnership based on shared issues among all the stakeholders will help reduce the trial delays. Such a shared vision will enable adherence to regulatory requirements, enhance the quality of trial conduct and ultimately enable improved access to new treatments and its benefits to the Indian population.\",\"PeriodicalId\":10369,\"journal\":{\"name\":\"Clinical investigation\",\"volume\":\"53 1\",\"pages\":\"745-753\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-10-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical investigation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4155/CLI.15.41\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical investigation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4155/CLI.15.41","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

我们的目标是为临床试验延迟的原因和后果提供广泛的视角,并提出以流程为导向和技术支持的务实解决方案,以最大限度地减少试验延迟,特别是在印度进行试验的背景下。成功完成临床试验的主要挑战来自监管和伦理审查、研究者选择、地点启动、参与者招募和保留、监测和数据管理问题。仔细规划,在最初步骤中理清所有权问题,并在所有利益相关者共享问题的基础上建立伙伴关系,将有助于减少试验延误。这种共同愿景将使遵守监管要求成为可能,提高试验行为的质量,并最终使印度人民能够更好地获得新疗法并从中受益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Solving clinical trial delays: innovative solutions
Our objective was to provide broad perspective on causes and consequences of clinical trial delays and suggest process-oriented and technology-enabled pragmatic solutions to minimize trial delays, in particular context of doing trials in India. The main challenges for successful completion of clinical trials stem from regulatory and ethics review, investigator selection, site initiations, participant recruitment and retention, monitoring and data management issues. Careful planning, sorting out ownership issues in the initial steps and a partnership based on shared issues among all the stakeholders will help reduce the trial delays. Such a shared vision will enable adherence to regulatory requirements, enhance the quality of trial conduct and ultimately enable improved access to new treatments and its benefits to the Indian population.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信